Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Cholib · 4.5 · Interactions relevant to monotherapies Inhibitors of CYP 3A4 Simvastatin is a substrate of cytochrome P450 3A4
Eintrag öffnenChromogene Verbindungen
Eintrag öffnenCialis · 4.5 · CYP1A2 substrates (e.g. theophylline) When tadalafil 10 mg was administered with theophylline (a non-selective
Eintrag öffnenCialis · 4.5 · CYP1A2 substrates (e.g. theophylline) When tadalafil 10 mg was administered with theophylline (a non-selective
Eintrag öffnenCialis · 4.5 · CYP1A2 substrates (e.g. theophylline) When tadalafil 10 mg was administered with theophylline (a non-selective
Eintrag öffnenCialis · 4.5 · CYP2C9 substrates (e.g. R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposu
Eintrag öffnenCialis · 4.5 · CYP2C9 substrates (e.g. R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposu
Eintrag öffnenCialis · 4.5 · CYP2C9 substrates (e.g. R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposu
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel HCS · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Krka · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel TAD · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · CYP2C8 substrate medicinal products Clopidogrel has been shown to increase repaglinide exposure in healthy vol
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenCotellic · 4.5 · BCRP substrates
Eintrag öffnenCotellic · 4.5 · CYP1A2 substrates
Eintrag öffnen